As much as I would *really* like it to be L., I agree with you. For example this quote from an article this morning: The potential for Moderna Inc. to file interim results with U.S. regulators from a 30,000-patient trial due to start by July 27 is underappreciated, analysts led by Salveen Richter said.
Granted that’s not KaC’s words, it still fits the bill.